Vanda Pharmaceuticals Announces Presentations at SLEEP 2024
WASHINGTON, May 29, 2024 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2024, to be held in Houston, TX from June 1 through June 5, 2024. The following will be presented: June 4, 2024 Presentation Title: “Drug Screening and CRISPR/Cas9 Screening of HCN Channels”Poster Presentation Session: P-17Poster Number: 10Presenter: Dr. Sandra … Read more
